ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0060124;positive regulation of growth hormone secretion;10.0;1.0;0.9152410118609203;9.628524252492122;554.2848301314677;7.57984905034425;0.0185514144405395;0.8028748447945538;[ADCYAP1]
GO:0060003;copper ion export;10.0;0.9326813400603323;0.8815816818910864;9.56398573135455;101.53169440817886;9.083926447120524;0.0033981744392491903;0.8797934328124444;[ATP7B]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[ANXA1, ADCYAP1]
GO:0006882;cellular zinc ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;329.3407122754199;6.375876246018314;0.011022737252460356;0.7413036195908642;[ATP7B, LCK]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, CCNH, SPIB, MYB, HOXA7, HOXA5, SOX4, MEF2A, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, HOXC10, PAX5, FOS, SIRT1, PAX2, FLNA, GTF2H1, GRHL2, CCNT2, ARID4A, HOXA10, C5AR1, HMGA1, NFKB1, COPS5, MAFF, MYOCD, ELF3, CREB5, CEBPE, TAF9, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, MEIS2, MEIS1, KLF5, POU2AF1, RBMX]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CXCR4, CDH1, PRDM16, EPHB1, TGFB2, ANXA1, NUP133, BCL11B, BCL11A, CIT, FABP7]
GO:0043267;negative regulation of potassium ion transport;8.0;0.7436939687323844;0.7468469843661922;9.0306872517365;68.61495707395616;6.444869117505266;0.00229648086381306;0.7045909063862833;[ADCYAP1, KCNE3, CAV1, KCNA5]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[LLGL2, EPHA2, RACGAP1, NCKAP1L, JUN, EZH2, ARHGAP9, DENND1B, NRP1, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP15, ADAP2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, LRRK2, TAGAP, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0048715;negative regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;472.5210628944727;7.292166977892469;0.015814854733730403;0.7881627702307852;[DUSP10, DAAM2]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[ATP7B, CCDC22]
GO:0001821;histamine secretion;8.0;0.7980440201809971;0.7740220100904985;9.303101852057495;92.71543055810072;7.8311634786251565;0.003103102022309413;0.7754860644832351;[LYN, ADCYAP1, BTK]
GO:0071651;positive regulation of chemokine (C-C motif) ligand 5 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.62106486279957;7.9853141584524145;0.0029660672871775788;0.7592887026755414;[ADCYAP1]
GO:0002878;negative regulation of acute inflammatory response to non-antigenic stimulus;9.0;1.0;0.896240625180289;9.628524252492122;203.39058958813945;9.777073627680469;0.0068072999938683385;0.896240625180289;[ADCYAP1]
GO:0070445;regulation of oligodendrocyte progenitor proliferation;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;81.49965491468586;7.697632086000634;0.0027277201050670686;0.7686572628545723;[LYN, ADCYAP1, LRP2]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[CELSR1, CDH3, AP2M1, SOX4, TLE4, SFRP4, HOXB9, SFRP2, CCNE1, DAAM2, PFN1, GATA3, APCDD1, FZD5, NR4A2, VANGL1, SDC1, CD24, CDK14, LRRK2, TGFB1I1, HHEX, AXIN2, AES, FRZB, CTHRC1, EGF, TMEM64, LGR4]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, EPHA3, LYN, SYT2, CXCL12, EZH2, ROBO2, NRP1, NLGN1, RAB21, PAK1, CNR1, FYN]
GO:0010656;negative regulation of muscle cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.485423408851448;104.61422944852276;6.250713103064308;0.003501344112948074;0.6946617587785947;[MYOCD, ADCYAP1, SFRP2]
GO:0051968;positive regulation of synaptic transmission, glutamatergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.83014596643335;6.375876246018314;0.004546112746301595;0.701062607729944;[ADCYAP1, NLGN1, TNR, PTGS2, KMO]
GO:0051205;protein insertion into membrane;7.0;0.7436939687323844;0.7227663496233927;9.081980546124052;54.49928435303714;6.641579411751319;0.0018240420011245825;0.6905700452391912;[REEP1, TRAM2]
GO:2000050;regulation of non-canonical Wnt signaling pathway;7.0;0.6799073451904818;0.6908730378524415;8.781226392104918;44.04846258837617;6.7325511899570465;0.0014742624017903352;0.6952223462072524;[SFRP4, SFRP2, DAAM2]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[LRRK2, KLRK1, PDE6D, RHOH, GMIP, ADCYAP1]
GO:0015680;intracellular copper ion transport;9.0;1.0;0.896240625180289;9.628524252492122;54.57636043096932;8.67846133901236;0.001826621668089006;0.8400575416471059;[ATP7B]
GO:0090263;positive regulation of canonical Wnt signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;236.52854047757646;5.244474134527214;0.007916397387918217;0.6432026511327102;[YAP1, LRRK2, RUVBL1, SOX4, JUP, EGF, CAV1, AXIN2, NFKB1, SULF2, COL1A1, SFRP4, SFRP2, DAAM2, LGR4, NAIP]
GO:0043950;positive regulation of cAMP-mediated signaling;8.0;0.8436909121759173;0.7968454560879586;9.517298617381897;239.5163045814748;6.686031174322154;0.008016395163662574;0.7169239451870815;[CXCL10, ADCYAP1, CXCL9, CXCL11, PF4]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[CALCA, CALCRL, PTGER2, ADRB2, GNAI2, PLN, PTGDR, ABCA1, LHCGR, PTGIR, TSHR, MC3R, ADCYAP1, ADCY9, RAMP1, LGR4]
GO:0008277;regulation of G-protein coupled receptor protein signaling pathway;6.0;0.5383299095163034;0.5922852673482962;7.5335785242763205;41.8512380110395;4.8942717050940985;0.0014007232725606145;0.5734135951955668;[, LRRK2, GUCA1C, RGS1, STMN1, ADCYAP1, ACPP, ADRB2, RASGRP4, GNAI2, CCL5, CAV2, RAMP1]
GO:0007218;neuropeptide signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;5.123113277522946;9.028936615729279E-4;0.5851165638517994;[CALCA, SORT1, NPY1R, GPR84, SORCS3, ADCYAP1, PNOC, PROK2, GPR19]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[, CCNH, TCL1A, AKT1, PROK2, TNFSF11, PRKACB, ACSL1, SLC11A1, MIF, PRKAR1B, FPR1, TGFA, IQGAP3, PRKAR2B, PDGFD, PDGFC, NCKAP1L, ELANE, EGR1, ACE, FZD5, CDC6, AZU1, PTK2, NOX4, CD24, EZH2, CDKN1A, CCR7, MAP4K1, SYK, SIRT1, DUSP6, MDFIC, IL1B, KIT, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CCL21, CD40LG, PKN1, CCNT2, TNF, IL6R, PDGFRB, MAP2K2, F2R, ADCYAP1, ADAM9, CALCA, C5AR1, TNFRSF11A, ADRB2, STAP1, DRD4, MAP2K6, TGFB2, TGFB1, TNFRSF10B, GH1, PTPRC, CSPG4, LAT, LRRK2, ITGB3, CYR61, GHR, GRM5, PSRC1, IFNG, CHI3L1, LCP2, PDE5A, LTF, THBS1, CCL5, FYN, CSK, EGF, MAPK14, CD4]
GO:0046034;ATP metabolic process;10.0;0.6519675769143192;0.7412248003180799;9.106334870075816;1262.3387643731025;4.99795013456894;0.04224934241243719;0.6708364141712261;[HK3, ATP1B1, ATP5J2, ADCYAP1, MSH2, UQCRC1, UQCRC2, UQCRB, ATP5J, ATP5I, ATP5H, ATP5O, COX5B, UQCRH, ATP5L, FIGNL1, CYC1, TGFB1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, VSTM1, TNFSF11, MEF2C, IFNA14, IFNA16, FLT3LG, MIF, BTC, ADCYAP1, SFRP2, IFNA10, CALCA, TGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, CXCL12, PNOC, OGN, CD320, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, CXCL1, FASLG, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, IFNG, IL1B, XCL1, HBEGF, CCL13, NLGN1, CLEC12B, RETN, CCL8, TTR, GPNMB, CCL7, CCL5, CCL4, NTF3, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, EGF, CCL20, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0019433;triglyceride catabolic process;8.0;1.0;0.875;9.628524252492122;492.4915826757067;6.518977089658987;0.01648325005850736;0.7083807915285978;[FABP7]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[TNF, PYCARD, CD36, IL6R, FCER1G, F2R, TLR1, ADCYAP1, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, HSPD1, CARD9, LILRB2, IL6, MYD88, IL17A]
GO:0015677;copper ion import;9.0;0.8933024483968273;0.8428918493787028;9.427853557029971;21.372061049954535;7.697632086000634;7.153036497357847E-4;0.7898978880348613;[STEAP4, ATP7B]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPINT2, PHB2, CYP1B1, EPHB1, SOX4, MEF2C, SFRP4, SFRP2, SPINT1, BTK, GATA3, INPP5D, SFN, LYN, JUN, BCL11B, FZD5, CDC6, NOX4, CDKN1A, TNFRSF13B, TGFB1I1, PRL, PTPRK, BRCA2, CTLA4, CD33, HAVCR2, DUSP1, ARG1, PAWR, PDCD1LG2, CEACAM1, IL1B, TLR2, PTGS2, PAK1, GPNMB, FRZB, PDPN, CCL23, CDKN2C, LILRB1, LILRB2, PODN, FABP7, PKN1, CD86, CD80, SIRPG, TNF, CDH5, DACH1, MEN1, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, CAV1, HMGA1, DHCR24, INHBA, IL6, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, IFNG, XCL1, PDE5A, DLL1, THBS1, CCL8, CCL2, ZNF503, CSK, E2F7, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MEF2C, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, IQGAP3, PDGFD, PDGFC, NCKAP1L, PLCG1, ELANE, LYN, JUN, CDC6, CDKN1A, HOXC10, TIMP1, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, PAX2, MMP12, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, F2R, MSH6, ADCYAP1, CD274, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, ITGB3, FASLG, CYR61, TNFSF13B, LBH, XCL1, CX3CR1, SMARCD3, LRP2, CCL5, CTHRC1, PRRX1, KLF5, DNAJA3, PTPN6, TCL1A, EDNRB, SKP2, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, BTC, SFRP2, TGFA, TWIST1, CD1D, PKHD1, EGR1, EGR3, TNFSF12, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, CTSZ, PRL, CD3E, ESM1, RAC2, CTSH, CCR2, SYK, RHOG, PDCD1LG2, AVPR1A, HCK, CEACAM6, IL1B, KIT, YAP1, GNAI2, PAK1, CXCR2, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IL6R, PDGFRB, GHSR, PDGFRA, CCNE1, PRTN3, CARD11, C5AR1, LTBP3, DPP4, TGFB2, TGFB1, CAV2, NR4A1, IL6, LIN28A, NR4A3, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, GLP2R, MMP9, TGFBR3, ZAP70, IFNG, NDUFS4, LTF, DLL1, THBS1, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, MIF, AURKAIP1, GATA3, TP53BP2, SFN, BARD1, PLK2, CDC6, ZWINT, STAG2, EZH2, CDKN1A, PTPRK, BRCA2, DUSP1, GAS1, PCNA, PTGS2, GPNMB, CDKN2C, LILRB1, SIPA1, GMNN, TNF, KNTC1, MEN1, MSH6, ADCYAP1, MSH2, BLM, CUL5, NACC2, NAE1, GAS2L1, MAP2K6, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BCL6, CNOT3, JMY, TNFAIP3, HHEX, TOPBP1, MYOCD, SMC1A, IFNG, PPP1R15A, THBS1, RBBP8, CCL2, BUB1, E2F7, MAPK14, WEE1, RAD51]
GO:0090274;positive regulation of somatostatin secretion;10.0;1.0;0.9152410118609203;9.628524252492122;554.2848301314677;9.083926447120524;0.0185514144405395;0.8797934328124444;[ADCYAP1]
GO:0008202;steroid metabolic process;4.0;0.566269677792466;0.5331348388962329;7.508260716292031;35.315100643705854;4.247644540169047;0.001181964637017687;0.4672247393199168;[CYP1B1, CUBN, PDGFRA, UGT2B15, UGT2B17, SLC27A2, CFTR, ABCA1, OSBPL7, SRD5A3, DHCR24, SULT4A1, HSD17B4, UGT2B28, LRP2, CYP3A4, CYP3A5, CYP3A7]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[ABCB4, CAV1, PRL, ATP7B]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, HOXA5, MEF2A, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, GATA3, NKX2-3, JUN, JAG1, JUP, FZD5, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, ENG, EPCAM, STAT4, NR1H2, ATAD2, GTF2H1, PSMC6, PSMC2, PF4, CCNT2, PLXND1, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, CXCL10, COPS5, MAFF, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, CEBPE, ABLIM3, E2F5, E2F7, PRRX1, KLF1, KLF5, POU2AF1, CCNH, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, SFRP2, BEX1, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, CD28, PRL, CD3D, RGMA, IL1B, TLR4, TLR2, YAP1, LILRB1, GRHL2, IL17A, ARID4A, ARID4B, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYOCD, CKAP2, DCN, ELF3, TAF9, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EHMT2, SLA2, MYB, HOXA2, HOXA7, MEF2A, MEF2C, HOXB4, HOXB3, ATF3, GATA3, PRDM16, ELANE, JUN, PKIG, EZH2, PAWR, PAX5, SIRT1, AES, MMP12, NR1H2, TNF, DACH1, MEN1, TLE4, FOXO1, NACC2, WFS1, NFKB1, BCL6, CIITA, FASLG, HHEX, RFC1, PEG3, RBBP8, E2F7, PRRX1, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX4, TWIST1, PCBP3, EGR1, BCL11A, ID1, XPO1, CD36, IL1B, LOXL2, CHCHD3, CCNE1, TGFB1, CBX4, CAV1, NR4A2, NR4A3, MXD1, MYOCD, IFNG, FBP1, MEIS2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[TNC, EEF1B2, ALAD, ADCYAP1, CLDN3, IL1B, CLDN7, S100A8, PSMD14, GATA3, CCL7, CNR1, FYN, GSN]
GO:0030326;embryonic limb morphogenesis;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;43.30626768056369;5.395046993006588;0.0014494218061579028;0.5661439659786197;[TWIST1, AFF3, HOXC10, HOXA11, HOXA10, TGFB2, PRRX1, RUNX2]
GO:0032386;regulation of intracellular transport;5.0;0.48838405180569167;0.534433037763766;6.898495144671136;27.751106644406903;3.8717117796258993;9.288045650137928E-4;0.48824053232399933;[, MAP1B, STXBP2, SFN, BARD1, LYN, JUP, FZD5, PKIG, CDKN1A, XPO1, RAC2, CD36, FCER1G, SYK, SIRT1, MDFIC, IL1B, GAS1, RHOU, PTGS2, PAK1, NUCB1, CHRM1, FMR1, CDH3, CDH1, IL13RA2, MAP2K2, TGFB1, REEP1, ITGAM, LRRK2, NUP62, PPP1R12A, FGR, IFNG, NUP54, NLGN1, RAB21, PLN, ABLIM3, FYN, MAPK14]
GO:0060253;negative regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;466.39591455460277;7.138016298065211;0.015609851531070574;0.7612791106150483;[ADCYAP1]
GO:0060134;prepulse inhibition;6.0;1.0;0.8231203125901445;9.628524252492122;45.20359748329822;7.212124270218933;0.0015129237271694644;0.6919486831672181;[FABP7]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[PRL, TGFB1, FOS, ADCYAP1, CLDN4, PNOC]
GO:0021520;spinal cord motor neuron cell fate specification;5.0;1.0;0.7902410118609202;9.628524252492122;21.520481055073958;7.8311634786251565;7.202711337377993E-4;0.6907270763441554;[HOXC10]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[INHBA, ADCYAP1, KIT]
GO:0001662;behavioral fear response;5.0;1.0;0.7902410118609202;9.628524252492122;37.889479621082295;6.375876246018314;0.0012681267845998157;0.6163036195908642;[GABRA5, DPP4, ADCYAP1, DRD4]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, FPR2, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CD24, GPR18, CXCL9, FASLG, JPH2, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, TRPC3, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR2, S1PR3, CCL1, CCL19, GPR157, CCL21, GPR6, P2RX5, CD4, F2RL3]
GO:0002865;negative regulation of acute inflammatory response to antigenic stimulus;9.0;0.7866048967936545;0.7895430735771163;9.423729839846109;536.8017184993446;8.16763571524637;0.017966270427991284;0.8139338954918922;[ADCYAP1, FCGR2B]
GO:0071385;cellular response to glucocorticoid stimulus;8.0;0.8436909121759173;0.7968454560879586;9.454170865347344;407.2980594846617;5.734022359845919;0.01363189950649617;0.6682381701418294;[ABCB4, FOXO1, TGFB1, ANXA1, ARG1, ADCYAP1]
GO:0097755;positive regulation of blood vessel diameter;7.0;0.7508913569872202;0.7263650437508107;9.0689084645567;39.67967046252893;5.845247994956144;0.0013280428609958766;0.6498456195510879;[DOCK5, CALCA, GCH1, PTAFR, ADRB2, ADCYAP1, EDNRB, PTGDR]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, C5AR1, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process;10.0;0.9326813400603323;0.8815816818910864;9.598671289342441;1067.6044110768958;6.599019797332524;0.035731758857152955;0.7527151911823093;[SLC35B3, SULT4A1]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[TNF, ANTXR1, MYOZ2, PDGFRB, MEF2A, PDGFRA, GAS2L3, CXADR, TPM1, DAAM2, TLN1, PFN1, LLGL2, CORO1A, EPB41L5, CNN1, RACGAP1, MYH14, MYH11, NCKAP1L, CORO2A, TBCK, BCL6, NRP1, ITGB5, LMOD1, ARHGEF10L, CXCL1, ANXA1, RHOG, GAB1, RHOH, PALLD, KIT, RHOU, FGD3, FGD4, PAK1, ABLIM3, FLNA, SORBS1, KRT19, ZYX]
